Loading company…
Pulmologix, a Stockholm company founded in 2014, develops respiratory health technology for healthcare providers.
Founded in 2014 and based in Stockholm, Sweden, Pulmologix develops technology for respiratory health, aimed at helping healthcare providers improve patient outcomes and clinical operations. Its Series B of EUR 9.6 mn, closed on September 22, 2014 with investors including Heartcore Capital and Novo Holdings, brought its total raised to EUR 9.6 mn. It plans to expand into additional European markets and parts of Asia by 2025. Its listed stage is Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in